Choate Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,070
Closed -$239K 365
2021
Q4
$239K Sell
3,070
-27
-0.9% -$2.38K 0.01% 262
2021
Q3
$296K Buy
3,097
+365
+13% +$38.5K 0.02% 224
2021
Q2
$340K Buy
2,732
+89
+3% +$10.6K 0.02% 207
2021
Q1
$348K Sell
2,643
-172
-6% -$23.5K 0.02% 205
2020
Q4
$373K Buy
2,815
+200
+8% +$24.2K 0.02% 187
2020
Q3
$267K Hold
2,615
0.02% 219
2020
Q2
$227K Buy
+2,615
New +$209K 0.02% 226

Other funds holding EXAS

Choate Investment Advisors's EXAS Position: Q1 2022 in Review

Choate Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 3,070 shares — an estimated $239K sold.

Choate Investment Advisors first reported a position in EXAS in Q2 2020 and held it in 7 quarters. The position peaked at $373K in Q4 2020. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Choate Investment Advisors reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • Choate Investment Advisors sold 3,070 Exact Sciences shares in Q1 2022, an estimated $239K.
  • Choate Investment Advisors first reported a position in Exact Sciences in Q2 2020 and held it in 7 quarters.
  • Choate Investment Advisors's Exact Sciences position peaked at $373K in Q4 2020.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Choate Investment Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.